Chemomab Therapeutics Ltd. logo
Healthcare & Life Sciences

Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd. is a Healthcare & Life Sciences startup based in Israel, most recent round Series B, 1 tracked investor.

Activeseries-b
series-b
Stage
1
Investors

About Chemomab Therapeutics Ltd.

Based in Israel, Chemomab Therapeutics Ltd. is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Chemomab Therapeutics is a clinical-stage biotechnology company developing nebokitug, a monoclonal antibody targeting the CCL24 protein to treat fibro-inflammatory diseases including liver, skin, and lung fibrosis.

Explore Chemomab Therapeutics Ltd.'s full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in Israel